3D bioprinted disease models
With $35M Bioprinting Investment Prellis Biologics Takes on New CEO
Organ bioprinting startup Prellis Biologics raised $35 million in a Series C round and plans to use the fresh capital to expand its proprietary, first-in-class human immune system-based drug discovery…
3D Printing News Briefs, February 19, 2022: Metal 3D Printing, Research, & More
Kicking things off in today’s 3D Printing News Briefs, Sciaky will deliver what it calls the “world’s largest” metal electron beam DED 3D printer to an aerospace customer. In research,…
Viscient Biosciences is Leveraging 3D Bioprinting for Drug Discovery
Biotechnology companies are uncovering new methods to develop drugs across a range of therapeutic areas. Looking to demonstrate a commitment to drug discovery and moving away from traditional laboratory animal…
Cellink and Viscient’s Projects Will Aid Pandemic Research
The novel COVID-19 outbreak has altered the world at its core, transforming the foundation of most companies as economies begin to shut down to avoid a healthcare system collapse. In…
